Analyst stock forecast
ResMed Forecast: $250.22 Analyst Target
Direct answer
ResMed's average price target is $250.22.
The target implies +13.2% from the recorded current price, and the consensus rating is Buy.
The low target implies -20.9%, the high target implies +44.7%, and the range spans 65.6% of the current price.
Forecast evidence checked October 1, 2026.
Get free ResMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $221.10
- Average price target
- $250.22
- High price target
- $320.00
- Low price target
- $175.00
- Low target gap
- -20.9%
- Target upside
- +13.2%
- High target gap
- +44.7%
- Target range width
- 65.6%
- Consensus rating
- Buy
- Analysts
- 17
- Evidence date
- October 1, 2026
- Valid through
- October 8, 2026
Explore related company data
Read the frequently asked questions.
What is ResMed's average price target?
ResMed's verified average price target is $250.22. The target range is $175.00 to $320.00.
How far are ResMed's low and high targets from the recorded price?
The low target implies -20.9%, while the high target implies +44.7%.
How many analysts are included in ResMed's consensus?
The verified consensus includes 17 analysts.
How is ResMed's target upside or downside calculated?
The average target of $250.22 is divided by the recorded price of $221.10, then one is subtracted to produce +13.2%. This does not guarantee a future return.
When was ResMed's analyst forecast verified?
The data was verified on 2026-10-01. The dataset is valid through 2026-10-08.